These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31971961)

  • 1. Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release.
    Akatsuka M; Masuda Y; Tatsumi H; Yamakage M
    PLoS One; 2020; 15(1):e0228093. PubMed ID: 31971961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis.
    Ogawa Y; Yamakawa K; Ogura H; Kiguchi T; Mohri T; Nakamori Y; Kuwagata Y; Shimazu T; Hamasaki T; Fujimi S
    J Trauma Acute Care Surg; 2012 May; 72(5):1150-7. PubMed ID: 22673239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Human Thrombomodulin Has Additive Effects in Septic Patients Undergoing Continuous Hemodiafiltration Due to Intestinal Perforation.
    Kono H; Hosomura N; Amemiya H; Kawaida H; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D
    Shock; 2021 Sep; 56(3):374-383. PubMed ID: 33595258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
    Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
    Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
    Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
    Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
    Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Ohara S; Sato M; Hosoya M
    Nephrol Dial Transplant; 2015 Jun; 30(6):969-77. PubMed ID: 25694534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
    Sakamoto S; Shimizu H; Isshiki T; Sugino K; Kurosaki A; Homma S
    Respir Investig; 2018 Mar; 56(2):136-143. PubMed ID: 29548651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
    Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
    J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Thrombomodulin in Renal Fibrosis of Nephrotoxic Serum Nephritis in Wistar-Kyoto Rats.
    Kanazawa N; Iyoda M; Tachibana S; Matsumoto K; Wada Y; Suzuki T; Iseri K; Shibata T
    Kidney Blood Press Res; 2020; 45(3):391-406. PubMed ID: 32146474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis.
    Yamakawa K; Murao S; Aihara M
    Thromb Haemost; 2019 Jan; 119(1):56-65. PubMed ID: 30597500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation.
    Heitrich M; García DM; Stoyanoff TR; Rodríguez JP; Todaro JS; Aguirre MV
    Biomed Pharmacother; 2016 Aug; 82():606-13. PubMed ID: 27470403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study.
    Akatsuka M; Masuda Y; Tatsumi H; Sonoda T
    J Intensive Care; 2020 Dec; 8(1):94. PubMed ID: 33308326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Human Thrombomodulin Reduces Mortality and Acute Lung Injury Caused by Septic Peritonitis in Rats.
    Kono H; Hosomura N; Amemiya H; Kawaida H; Furuya S; Shoda K; Akaike H; Kawaguchi Y; Ichikawa D
    Immunohorizons; 2023 Jan; 7(1):159-167. PubMed ID: 36706425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic rats.
    Iba T; Miki T; Hashiguchi N; Tabe Y; Nagaoka I
    Thromb Res; 2014 Jul; 134(1):169-73. PubMed ID: 24816370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.